|
XPNPEP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.577660E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.789300E-04 |
| Normal-vs-Stage2 |
2.024400E-01 |
| Normal-vs-Stage3 |
8.40600000000524E-05 |
| Normal-vs-Stage4 |
3.801100E-04 |
| Stage1-vs-Stage2 |
5.006000E-01 |
| Stage1-vs-Stage3 |
1.625230E-01 |
| Stage1-vs-Stage4 |
1.837240E-01 |
| Stage2-vs-Stage3 |
1.602030E-01 |
| Stage2-vs-Stage4 |
1.415590E-01 |
| Stage3-vs-Stage4 |
8.067200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.2458000000003E-05 |
| Normal-vs-AfricanAmerican |
6.223800E-01 |
| Normal-vs-Asian |
2.982000E-02 |
| Caucasian-vs-AfricanAmerican |
4.323900E-02 |
| Caucasian-vs-Asian |
3.451000E-01 |
| AfricanAmerican-vs-Asian |
2.637800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.43479999999719E-05 |
| Normal-vs-Female |
9.399500E-04 |
| Male-vs-Female |
9.838000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.123710E-03 |
| Normal-vs-Age(41-60Yrs) |
2.234500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.121920E-02 |
| Normal-vs-Age(81-100Yrs) |
4.234300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.568200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.836400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.785000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.589600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.466000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.417200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.593200E-01 |
| Classical-VS-Follicular |
3.035600E-01 |
| Classical-VS-Other |
3.129400E-01 |
| Classical-VS-Normal |
1.164410E-04 |
| Tall-VS-Follicular |
1.849150E-01 |
| Tall-VS-Other |
5.654200E-01 |
| Tall-VS-Normal |
1.463520E-03 |
| Follicular-VS-Other |
3.142000E-01 |
| Follicular-VS-Normal |
8.512100E-02 |
| Other-VS-Normal |
8.144800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.793100E-04 |
| Normal-vs-N1 |
1.36780000004055E-06 |
| N0-vs-N1 |
3.458300E-02 |
|
|
